Safacto AF® 500IU Factor VIII Injection In Pakistan

Safacto AF® 500IU is a recombinant Factor VIII replacement therapy developed by Saman Daroo 8, used to treat and prevent bleeding episodes in patients with Hemophilia A (factor VIII deficiency). Safacto AF® 500IU Injection is a recombinant human Coagulation Factor VIII medicine used for the treatment and prevention of bleeding episodes in patients with Hemophilia A (Factor VIII deficiency).

It contains recombinant Factor VIII, a clotting protein produced using recombinant DNA technology. This medicine helps replace the missing or insufficient Factor VIII in the blood, supporting the normal blood-clotting process and helping control bleeding.

Safacto AF® is manufactured by Saman Daroo 8, Iran, and is intended for use under the supervision of a qualified hematologist or healthcare professional.

Product Information

Uses of Safacto AF® 500IU Injection

Safacto AF® is used for the management of Factor VIII deficiency in patients with Hemophilia A.

Its medical uses include:

1. Treatment of Hemophilia A

Helps manage bleeding episodes in patients with congenital Factor VIII deficiency.

2. Prevention of Bleeding Episodes

May be prescribed as preventive treatment to reduce the frequency of bleeding episodes.

3. Bleeding Management

Helps control bleeding associated with Factor VIII deficiency.

4. Surgical Bleeding Management

May be used to manage bleeding before, during, and after surgical procedures in patients with Hemophilia A.

How Does Safacto AF® Work?

Safacto AF® contains recombinant Coagulation Factor VIII, which plays an essential role in the blood-clotting process.

In patients with Hemophilia A, the body does not produce enough functional Factor VIII. This deficiency makes it difficult for blood to clot properly.

Safacto AF® replaces the deficient clotting factor and supports the coagulation cascade, helping the body form stable blood clots and control bleeding.

Benefits of Safacto AF® 500IU

• Provides recombinant Factor VIII replacement therapy.

• Helps control bleeding episodes associated with Hemophilia A.

• Supports normal blood-clotting activity.

• May help prevent recurrent bleeding episodes.

• Can be used as part of a specialist-prescribed treatment plan.

• May support bleeding management during surgical procedures.

Dosage and Administration

Safacto AF® 500IU is administered intravenously after reconstitution with the supplied solvent.

The appropriate dose depends on several factors, including:

• Patient's body weight.

• Severity of Factor VIII deficiency.

• Location and severity of bleeding.

• Target Factor VIII activity levels.

• Individual response to treatment.

Important Administration Guidelines:

• Use only under the supervision of a qualified hematologist.

• Reconstitute according to the manufacturer's instructions.

• Administer through the recommended intravenous route.

• Do not use without appropriate medical guidance.

• Do not mix with other medicines unless specifically instructed.

Possible Side Effects

Some patients may experience side effects during treatment with recombinant Factor VIII.

Possible side effects include:

• Headache.

• Fever.

• Nausea.

• Vomiting.

• Injection-site reactions.

• Skin rash.

• Itching.

• Allergic reactions.

Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reactions.

• Difficulty breathing.

• Facial or throat swelling.

• Signs of anaphylaxis.

• Unexpected or persistent bleeding.

Some patients may develop Factor VIII inhibitors (antibodies), which can reduce the effectiveness of treatment.

Warnings and Precautions

Before using Safacto AF® 500IU Injection:

• Inform your doctor about any known allergies.

• Tell your healthcare provider about previous reactions to Factor VIII products.

• Inform your doctor if you have developed Factor VIII inhibitors.

• Report any unusual bleeding or allergic symptoms.

• Follow the prescribed treatment schedule.

• Use only under specialist medical supervision.

Storage Instructions

• Follow the manufacturer's recommended storage conditions.

• Protect the product from direct sunlight.

• Do not freeze unless specifically permitted by the manufacturer.

• Keep the medicine in its original packaging.

• Use the supplied solvent and reconstitution equipment as instructed.

• Keep out of reach of children.

Safacto AF® 500IU Injection Price in Pakistan

The price of Safacto AF® 500IU Factor VIII Injection in Pakistan / 11000